What Are B Cells?

There are two major types of lymphocytes: B-cells and T-cells.

B-cells, also known as B lymphocytes, are one of several types of white blood cells in the body that are produced in the bone marrow through a process called hematopoiesis, which is the formation and development of both red and white blood cells.

B-cells roam the body as part of our immune system, protecting us from foreign antigens that pose a threat to our health.

Why the letter B?

B-cells get their name not from research done into human anatomy but from research done into the anatomy of birds. But 'birds' isn't the origin of the B; instead, B-cells were named after the site in birds where this specific type of blood cell matures, called the bursa of Fabricius. Fortunately, in humans and many other mammals B-cells mature in the bone marrow, allowing the B to continue to make sense.

To that end, T-cells get their letter designation from the site where they mature too; in this case, it is the thymus.

The role of B-cells

Once they mature, B-cells leave the bone marrow and begin to circulate throughout the body by way of the blood and lymphatic system, or they might hang around in any one of the many lymphoid organs (thymus, lymph nodes, spleen).

B-cells are distinct from other cells in the immune system by their display of membrane-bound immunoglobin molecules. This means that on the surface of a single B-cell there are thousands of molecules of antibody, and they all have an identical binding site for antigen.

When that specific binding site on the cell meets the antigen that matches it, it kicks in an adaptive immune response to this threat: the B-cell begins to divide very quickly. In doing so, it creates two types of daughter cells: plasma cells and memory B cells, both of which have a separate function in the immune system.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap